S&P Biotech SPDR (XBI)
$83.58
0.79 (0.95%)
XBI Stock Quote Delayed 15 Minutes
Previous Close
$82.79
Market Cap
4.52B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
2.41M
Day's Range
82.46 - 83.72
52-Week Range
64.38 - 97.60
Dividend & Yield
0.23 (0.27%)
XBI Stock Predictions, Articles, and S&P Biotech SPDR News
The Move in SPDR S&P Biotech (ETF) (XBI) ETF Is Coming — Get on Board
The biotech trade is always a momentum bet, and currently Wall Street is betting it will go up. I can use this play in XBI for free income.
Amgen, Inc. (AMGN) Stock Is a Trade for Ailing Portfolios
Investors fear Amgen (AMGN) is a falling knife after dropping on earnings. Use that fear to sell puts for income in AMGN stock.
The Bulls’ Banner Waves in the SPDR S&P Biotech (ETF) (XBI)
The SPDR S&P Biotech ETF is forming a bull flag. Here's how to play biotech stocks for profit in XBI.
Dipping Celgene Corporation (CELG) Stock Is Begging to Be Bought
Biotech stocks, including Celgene, are pulling back. CELG stock is one of the best dip-buying opportunities of the bunch.
Play the iShares Nasdaq Biotechnology Index (ETF)’s (IBB) Popularity for Free
ETFs should not move 11% in four days. The IBB just did that, so I will short it with no money out of pocket. Bet against the herd mentality.
Is the SPDR S&P Biotech (ETF) (XBI) Done Running?
Biotech stocks are booming, but resistance looms close. Time to take profits on the SPDR S&P Biotech (ETF) XBI calls, but also consider reloading.
Trade of the Day: SPDR S&P Biotech (ETF) (XBI)
XBI hit a new 52-week high of $76.60 on Tuesday before easing back slightly to about $75. And I'm opting to employ one of my preferred bullish strategies here.
The SPDR S&P Biotech (ETF) (XBI) Is on Breakout Watch
Biotech stocks are quietly climbing higher. Here's how to trade the SPDR S&P Biotech (ETF) (XBI) before its seemingly imminent pop.
Direxion Daily S&P Biotech Bear 3X Shares (LABD): The Quick Guide to LABD
Like other leveraged ETFs, Direxion Daily S&P Biotech Bear 3X Shares (LABD) seduces with big potential gains when biotech stocks drop.
How to Profit From the Bulls’ Return to Biotech Stocks (XBI)
Biotech stocks are making a comeback. Use this bullish XBI play to capitalize on continued strength in the sector.
Is Now the Time to Buy Into These 5 Biotech ETFs?
After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out
Buy Today’s Trump Dump in Biotech Stocks – XBI IBB
Biotech stocks and ETFs like iShares' IBB and SPDR's XBI were hammered Wednesday on Donald Trump's drug pricing comments. Opportunity knocks.
SPDR S&P Biotech (ETF) (XBI): Get on Board the Biotech Train!
Biotech stocks have gained the wind, but the SPDR S&P Biotech (ETF) (XBI) hasn't yet caught up with the market. That's going to change soon.
Surf the Biotech Channel with the SPDR S&P Biotech (ETF) (XBI)
The biotech stock pop is fading, but opportunity lurks for bulls and bears, and you can use the XBI ETF to make some money on its next move.
Try the SPDR S&P Biotech (ETF) (XBI) if You’re Bullish on the Biotech Pause
Biotech stocks remain under accumulation post-election. Play XBI on the cheap to profit from the expected continued upside.
Buy the SPDR S&P Biotech (ETF) (XBI) TODAY – Here’s Why
Biotech stocks and the SPDR S&P Biotech ETF (XBI) just shook off a major bugaboo in Hillary Clinton. The XBI ETF will soar as a result.
Three Big Stock Charts: Metlife Inc (MET), Apple Inc. (AAPL) and SPDR S&P Biotech ETF (XBI)
Apple (AAPL) and the SPDR S&P Biotech ETF (XBI) are going to see selling pressure while Metlife (MET) is unlikely to see the same decline.
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
